requirements of your position. Some of what you will be doing include: Oracle NetSuite Maintenance and Configuration... functionalities. - Manage and maintain Oracle NetSuite, ensuring optimal configuration to support business operations. - Customize...
Solution Architect - Oracle ERP (EBS and Fusion Apps) NextLabs is looking for a highly motivated Solution Architect who... is passionate about developing complex solutions for our strategic customers using the NextLabs Data-centric security for Oracle...
Maintenance/Production Support Type B L2 Support General Junior L2 (3-5 years) Informatica ETL Oracle/MSSQL/MYSQL SQL & Shell... Technical skills : Oracle / MS SQL, Unix/Linux, AS400, Control-M, Shell scripting, Informatica 3. Willing to work in 24x7...
JD for L2: Support Specialist: Provide second-level support for Oracle ERP finance modules, including General Ledger... incidents related to Oracle ERP functionality, user access, system performance, and data integrity. Trouble shoot Oracle Fusion...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »